Genetic Engineering Applications
Recombinant human proteins made by GM bacteria, yeast or animals: insulin, factor VIII (haemophilia), adenosine deaminase; purer and more plentiful than animal sources. Gene therapy adds a working allele to treat genetic disease (e.g. SCID, cystic fibrosis) using viral vectors or liposomes; somatic therapy affects only the patient, germ-line would be inherited (banned in humans). Genetic screening detects alleles (e.g. BRCA1, CF) with DNA probes; genetic counselling helps people decide. PGD screens IVF embryos. GM crops: Bt maize (insect resistance), herbicide-tolerant soya, Golden Rice (β-carotene for vitamin A). DNA profiling uses variable repeat sequences, PCR and electrophoresis for forensics and paternity. Ethical issues: safety, gene flow to wild plants, monopolies, consent, designer babies.
Learning objectives
- Describe uses of recombinant proteins.
- Describe gene therapy and its challenges.
- Describe genetic screening and profiling.
- Evaluate GM crops and ethical issues.
Why does gene therapy for cystic fibrosis have to be repeated?
Core idea
The insulin keeping millions of people alive is made by genetically modified microorganisms.
Gene technology provides proteins, therapies, tests and crops, but each use raises questions of safety and ethics.
Benefits with matching concerns.
Three independent markers, each 1 in 20.
- Goal
- Probability of random match.
- Strategy
- Multiply.
- Independent events.
- Evaluate.
Summary
- Recombinant proteins.
- Gene therapy.
- GM crops; profiling; ethics.
- Gene therapy
- Inserting a functional allele to treat a genetic disorder.
- DNA profiling
- Comparing variable DNA regions to identify individuals.
Create a free account to read the rest of this lesson: key formulae, worked examples, explore the graph, common mistakes, exam tip, guided practice and more. Your answers are checked and your progress is saved.